# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Barclays analyst Adam Seiden maintains Blue Bird (NASDAQ:BLBD) with a Overweight and raises the price target from $35 to $43.
Roth MKM analyst Craig Irwin maintains Blue Bird (NASDAQ:BLBD) with a Buy and raises the price target from $40 to $43.
Needham analyst Chris Pierce maintains Blue Bird (NASDAQ:BLBD) with a Buy and raises the price target from $44 to $52.